dual tubulin polymerization/CDC20 homolog inhibitors (Central South University/Hubei University of Medicine)

N/A

Report date: 2025/03/18 18:15:36
NME

Base Information

Drug Namedual tubulin polymerization/CDC20 homolog inhibitors (Central South University/Hubei University of Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle protein 20 homolog inhibitorsTubulin depolymerization inhibitors
TargetsCell division cycle protein 20 homologTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCentral South University
China Registration ClassN/A

Develop Information

Active CompaniesHubei University of MedicineCentral South University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A